Sanofi asks to pull Tzield bid from FDA's controversial CNPV program: report

6th May 2026 Uncategorised 0

The FDA’s Commissioner’s National Priority Voucher program has been steeped in controversy since its inception. Now, Sanofi has asked that one of its applications be taken out of the fast-track program, according to Stat.

More: Sanofi asks to pull Tzield bid from FDA's controversial CNPV program: report
Source: fierce